Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 AUD | +4.35% | +14.29% | +118.18% |
04-09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
02-28 | Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Anatara Lifesciences Ltd
Upcoming events on Anatara Lifesciences Ltd
Past events on Anatara Lifesciences Ltd
2024-02-27 19:52 | Q2 2024 Earnings Release |
2024-01-23 17:36 | December 2023 Sales and Revenue Release - Activities Report |
2023-11-09 18:30 | Annual General Meeting |
2023-10-18 | Irritable Bowel Syndrome Stage 1 Clinical Trial Results Call |
2023-08-23 19:33 | Q4 2023 Earnings Release |
2023-07-18 18:20 | June 2023 Sales and Revenue Release - Activities Report |
2023-04-19 18:07 | March 2023 Sales and Revenue Release - Activities Report |
2023-02-23 17:08 | Interim 2023 Earnings Release |
2023-01-11 16:21 | December 2022 Sales and Revenue Release - Activities Report |
2022-12-11 | Shareholders Meeting |
2022-11-10 | Annual General Meeting |
2022-08-28 | FY 2022 Earnings Release |
2022-07-31 19:02 | June 2022 Sales and Revenue Release - Activities Report |
2022-04-28 | March 2022 Sales and Revenue Release - Activities Report |
2022-02-23 17:59 | Interim 2022 Earnings Release |
2022-01-26 | December 2021 Sales and Revenue Release - Activities Report |
2021-12-08 | Gastro Congress |
2021-11-16 | Microbiome Connect Conference |
2021-11-15 | Annual General Meeting |
2021-11-03 | USA Microbiome R&D and Business Collaboration Forum |
Annual results
Fiscal Period | June | 2019 |
---|---|---|
Net sales Million AUD | Released Forecast Spread | 1,50 1,70 -11.51% |
EBITDA Million AUD | Released Forecast Spread | -2,99 -2,90 -3.04% |
EBIT Million AUD | Released Forecast Spread | -3,01 -3,10 2.88% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - |
Net income Million AUD | Released Forecast Spread | -2,87 -2,60 -10.32% |
EPS AUD | Released Forecast Spread | -0,06 -0,05 -12.38% |
Announcement Date | 26/08/19 |
Today 06:25 | ELI LILLY AND COMPANY: Q1 2024 Earnings Release |
2024-04-30 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 02:00 | GSK PLC: Q1 2024 Earnings Release |
2024-05-01 03:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
2024-05-01 06:45 | PFIZER, INC.: Q1 2024 Earnings Release |
2024-05-01 16:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
2024-05-01 16:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
Past sector events for Anatara Lifesciences Ltd
- Stock Market
- Equities
- ANR Stock
- Calendar Anatara Lifesciences Ltd